A Phase I trial on fractionated intracavitary radioimmunotherapy and patient-specific dosimetry with Lu-177 labeled 6A10 Fab-fragments in newly diagnosed glioblastoma (RIT in GBM)
Basic data for this project
Type of project: Own resources project
Duration at the University of Münster: since 01/01/2017